Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$79.03
+1.6%
$75.73
$64.95
$86.20
$14.98B0.594,707 shs566 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$309.47
-1.9%
$273.73
$244.52
$316.11
$25.38B0.89693,187 shs1.09 million shs
Natera, Inc. stock logo
NTRA
Natera
$267.76
-0.7%
$245.48
$131.81
$288.04
$38.35B1.511.35 million shs1.33 million shs
Viatris Inc. stock logo
VTRS
Viatris
$17.56
-1.1%
$16.44
$8.63
$18.07
$20.45B0.9110.44 million shs15.57 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eurofins Scient stock logo
ERFSF
Eurofins Scient
-3.08%+5.10%-1.02%+15.30%+0.78%
Labcorp Holdings Inc. stock logo
LH
Labcorp
+2.83%+8.71%+13.09%+22.92%+19.60%
Natera, Inc. stock logo
NTRA
Natera
+6.24%+1.88%-0.66%+30.80%+91.30%
Viatris Inc. stock logo
VTRS
Viatris
-0.34%+2.78%+11.84%+18.88%+97.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$79.03
+1.6%
$75.73
$64.95
$86.20
$14.98B0.594,707 shs566 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$309.47
-1.9%
$273.73
$244.52
$316.11
$25.38B0.89693,187 shs1.09 million shs
Natera, Inc. stock logo
NTRA
Natera
$267.76
-0.7%
$245.48
$131.81
$288.04
$38.35B1.511.35 million shs1.33 million shs
Viatris Inc. stock logo
VTRS
Viatris
$17.56
-1.1%
$16.44
$8.63
$18.07
$20.45B0.9110.44 million shs15.57 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eurofins Scient stock logo
ERFSF
Eurofins Scient
-3.08%+5.10%-1.02%+15.30%+0.78%
Labcorp Holdings Inc. stock logo
LH
Labcorp
+2.83%+8.71%+13.09%+22.92%+19.60%
Natera, Inc. stock logo
NTRA
Natera
+6.24%+1.88%-0.66%+30.80%+91.30%
Viatris Inc. stock logo
VTRS
Viatris
-0.34%+2.78%+11.84%+18.88%+97.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eurofins Scient stock logo
ERFSF
Eurofins Scient
2.33
HoldN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.75
Moderate Buy$323.274.46% Upside
Natera, Inc. stock logo
NTRA
Natera
2.82
Moderate Buy$267.830.03% Upside
Viatris Inc. stock logo
VTRS
Viatris
2.57
Moderate Buy$17.50-0.34% Downside

Current Analyst Ratings Breakdown

Latest ERFSF, NTRA, LH, and VTRS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetOverweight$308.00 ➝ $338.00
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Reiterated RatingHold$306.00
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Set Price Target$352.00
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetBuy$320.00 ➝ $350.00
7/30/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetEqual Weight$290.00 ➝ $320.00
7/24/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
UpgradeBuy (B-)Buy (B)
7/23/2026
Viatris Inc. stock logo
VTRS
Viatris
UpgradeSell (D+)Hold (C-)
7/17/2026
Natera, Inc. stock logo
NTRA
Natera
Reiterated RatingSell (D-)
7/15/2026
Natera, Inc. stock logo
NTRA
Natera
Reiterated RatingBuy
7/14/2026
Natera, Inc. stock logo
NTRA
Natera
DowngradeHoldStrong Sell
7/14/2026
Natera, Inc. stock logo
NTRA
Natera
Boost Price TargetBuy$285.00 ➝ $330.00
(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$8.25B1.82$7.09 per share11.14$30.19 per share2.62
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.95B1.82$25.02 per share12.37$103.98 per share2.98
Natera, Inc. stock logo
NTRA
Natera
$2.31B16.63N/AN/A$12.38 per share21.63
Viatris Inc. stock logo
VTRS
Viatris
$14.56B1.40$7.29 per share2.41$12.77 per share1.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$537.29MN/AN/AN/AN/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$876.50M$11.2927.4116.012.046.66%16.29%7.62%N/A
Natera, Inc. stock logo
NTRA
Natera
-$208.16M-$1.63N/AN/AN/A-9.05%-14.74%-10.27%8/6/2026 (Estimated)
Viatris Inc. stock logo
VTRS
Viatris
-$3.51B-$0.26N/A6.581.62-2.04%19.04%7.62%8/6/2026 (Estimated)

Latest ERFSF, NTRA, LH, and VTRS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Natera, Inc. stock logo
NTRA
Natera
-$0.4977N/AN/AN/A$661.24 millionN/A
8/6/2026Q2 2026
Viatris Inc. stock logo
VTRS
Viatris
$0.62N/AN/AN/A$3.68 billionN/A
7/30/2026Q2 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.78$4.99+$0.21$3.64$3.71 billion$3.73 billion
5/7/2026Q1 2026
Viatris Inc. stock logo
VTRS
Viatris
$0.52$0.59+$0.07$0.15$3.36 billion$3.52 billion
4/30/2026Q1 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.09$4.25+$0.16$3.35$3.51 billion$3.54 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.880.93%N/A25.51%N/A
Natera, Inc. stock logo
NTRA
Natera
N/AN/AN/AN/AN/A
Viatris Inc. stock logo
VTRS
Viatris
$0.482.73%N/AN/A N/A

Latest ERFSF, NTRA, LH, and VTRS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/9/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.04%8/28/20268/28/20269/11/2026
5/4/2026
Viatris Inc. stock logo
VTRS
Viatris
quarterly$0.122.88%5/22/20265/22/20266/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.68
1.73
1.54
Natera, Inc. stock logo
NTRA
Natera
N/A
2.96
2.83
Viatris Inc. stock logo
VTRS
Viatris
0.85
1.60
1.03

Institutional Ownership

CompanyInstitutional Ownership
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Natera, Inc. stock logo
NTRA
Natera
99.90%
Viatris Inc. stock logo
VTRS
Viatris
79.88%

Insider Ownership

CompanyInsider Ownership
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Natera, Inc. stock logo
NTRA
Natera
5.05%
Viatris Inc. stock logo
VTRS
Viatris
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eurofins Scient stock logo
ERFSF
Eurofins Scient
62,696189.62 millionN/ANot Optionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
71,00082.00 million81.31 millionOptionable
Natera, Inc. stock logo
NTRA
Natera
6,140143.21 million135.98 millionOptionable
Viatris Inc. stock logo
VTRS
Viatris
30,0001.16 billion1.16 billionOptionable

Recent News About These Companies

J.P. Morgan Sticks to Its Hold Rating for Viatris (VTRS)
UBS Reaffirms Their Buy Rating on Viatris (VTRS)
Viatris Inc.
5 Most Undervalued NASDAQ Stocks to Buy Right Now

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eurofins Scient stock logo

Eurofins Scient OTCMKTS:ERFSF

$79.03 +1.23 (+1.58%)
As of 03:56 PM Eastern

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Labcorp stock logo

Labcorp NYSE:LH

$309.47 -6.06 (-1.92%)
Closing price 03:59 PM Eastern
Extended Trading
$309.53 +0.06 (+0.02%)
As of 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Natera stock logo

Natera NASDAQ:NTRA

$267.76 -1.90 (-0.70%)
Closing price 04:00 PM Eastern
Extended Trading
$266.17 -1.59 (-0.59%)
As of 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.

Viatris stock logo

Viatris NASDAQ:VTRS

$17.56 -0.20 (-1.13%)
Closing price 04:00 PM Eastern
Extended Trading
$17.24 -0.31 (-1.79%)
As of 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.